Export Growth Cooper Pharma operates a robust export engine since 1999, currently present in 24 countries and supported by Cooper International in Dubai, presenting a scalable pathway to expand into new regional markets and cross-border licensing deals.

Manufacturing Power With a state‑of‑the‑art manufacturing unit certified by ANSM, Saudi FDA, and GMP Morocco, there is an opportunity to position Cooper Pharma as a trusted supplier for generic and licensed medicines to public health programs and private distributors seeking compliant, high‑quality production.

Diversified Channel A multi‑modal footprint including eight distribution centers and an in‑house wholesale arm enables end‑to‑end sales solutions for developers, distributors, and regional partners, making Cooper Pharma an attractive partner for joint ventures and exclusive distribution rights.

Therapeutic Reach With a broad portfolio of 100+ own brands and licensed medicines across major therapeutic areas, there are opportunities to upsell high‑demand generics and brand‑name equivalents to hospital and outpatient channels, as well as tenders for public procurement.

Strategic Alliances Cooper Pharma already collaborates with about twenty multinational manufacturers, suggesting potential for new licensing arrangements, private label opportunities, and expansion of a regional portfolio through co‑development or co‑marketing agreements.